The need to eradicate the infection represents a significant motivational reason for the abstention.

Antibiotics can eradicate the infection, but it takes months.

However, current antiviral therapies are usually unable to achieve sustained off-treatment responses and eradicate the infection.

H. pylori leads to chronic inflammation because of the failure of the host to eradicate the infection.

Conventional treatment with antibiotics often fails to eradicate the infection; even when it succeeds, recurrent infection is common.

Latency-reversing agents (LRAs) activate these cells, allowing for their potential clearance, thus presenting a strategy to eradicate the infection.

Early intervention with appropriate treatment offers the best opportunity for eradicating the infection and promoting maximal neurological recovery.